As AG Momentum Continues, Mucosta AG to Hit Shelves 8 Years after Gx Entry

By Takashi Ebisawa As authorized generics (AGs) capture the lion’s share of their respective generic market in Japan, the Otsuka group is to roll out an AG version of its peptic ulcer med Mucosta (rebamipide) eight years after the drug’s...read more